Defining the Ablative Dose for Y-90 TARE

This study is being done to help doctors improve how they treat liver tumors that cannot be removed by surgery or treated with standard ablation techniques. The researchers want to find out the best amount of radiation that needs to be delivered to completely destroy (or ablate) parts of the liver that have cancer.

NCT Number	NCT07586046
Lead Sponsor	Northwestern University Collaborators: Radiological Society of North America, Robert H. Lurie Cancer Center
Conditions	HCC - Hepatocellular Carcinoma
Enrollment	30 participants
Start Date	2026-05
Primary Completion	2029-02 (estimated)
Study Completion	2029-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-14